ACM Research CEO David H. Wang sells $3.55 million in stock

Published 14/03/2025, 02:32
ACM Research CEO David H. Wang sells $3.55 million in stock

FREMONT, CA—David H. Wang, the Chief Executive Officer, President, and Director of ACM Research, Inc. (NASDAQ:ACMR), recently executed a series of stock sales amounting to approximately $3.55 million. The transactions come amid ACMR’s impressive 81.7% year-to-date stock surge and strong financial health rating from InvestingPro. The sales, conducted over three consecutive days, involved the sale of Class A Common Stock at prices ranging from $26.57 to $27.65 per share.

On March 11, Wang sold 56,250 shares at a weighted average price of $26.57. The following day, he sold an additional 37,500 shares at an average price of $27.42. On March 13, sales continued with 36,481 shares sold at an average price of $27.29, followed by a smaller tranche of 1,019 shares at $27.65. These sales were executed under a Rule 10b5-1 trading plan, which Wang adopted in May 2024 and amended in August 2024. The transactions occurred as ACMR, with its $1.74 billion market capitalization, trades near its 52-week high of $33.40.

Following these transactions, Wang retains direct ownership of 672,708 shares. Additionally, indirect holdings include shares owned by family members and trusts. The sales were part of a pre-arranged trading plan, allowing for systematic stock disposition without the influence of market conditions. According to InvestingPro analysis, ACMR currently appears undervalued, with 12 additional ProTips available to subscribers examining the company’s growth potential and financial stability.

In other recent news, ACM Research reported strong financial results for the fourth quarter of 2024, exceeding Wall Street forecasts. The company achieved an earnings per share of $0.56, surpassing the projected $0.3357, and recorded revenue of $223.5 million, which was above the expected $181.08 million. This marked a 31.2% increase in revenue compared to the previous year. Furthermore, ACM Research’s full-year revenue reached $782.1 million, representing a 40.2% increase from the prior year. The company projects 2025 revenue between $850 million and $950 million, indicating a potential 15% year-over-year growth.

Additionally, JPMorgan initiated coverage on ACM Research with an Overweight rating and set a price target of $36.00. This endorsement highlights the company’s strong position in the semiconductor industry and its growth potential, particularly within the Chinese market. ACM Research’s robust customer base and its advancements in wafer cleaning and electrochemical plating technologies were key factors in JPMorgan’s positive outlook. These developments underscore ACM Research’s strategic efforts to expand its product offerings and enhance its technology portfolio in response to evolving industry needs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.